Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma and other neoplasias.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
HMS faculty, help us improve the algorithms in Profiles by
uploading your CV!
Return to Top
Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma and other neoplasias.
Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma and other neoplasias. Expert Opin Investig Drugs. 2001 Aug; 10(8):1521-30.
View in:
PubMed
subject areas
Animals
Antibiotics, Antineoplastic
Antineoplastic Agents
Apoptosis
Apoptosis Regulatory Proteins
Doxorubicin
Enzyme Inhibitors
Humans
Membrane Glycoproteins
Multiple Myeloma
Neoplasms
Signal Transduction
TNF-Related Apoptosis-Inducing Ligand
Tumor Necrosis Factor-alpha
authors with profiles
Steven P. Treon, M.D., Ph.D.